SavedAdd your journal

Journals / Türk Yoğun Bakım Dergisi / 2021 / Cilt: 19 - Sayı: 1

Lactate/Albumin Ratio as a Prognostic Factor for Short-time Mortality in Critically Ill Patients with Coronavirus Disease-2019

Yoğun Bakım Ünitesinde Takip Edilen Koronavirüs Hastalığı-2019 Olgularında Kısa Dönem Mortalitenin Prognostik Belirteci Olarak Laktat/Albümin Oranı

Leman Acun DELEN
Umut Sabri KASAPOĞLU
Abdullah GÖK
Ferman ÖZMEN
Süsen BANAZLI
Pages
62–72
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients who died within 30 days had higher lactate (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The prognostic role of the initial lactate/albumin ratio (LAR) in critically ill patients with coronavirus disease-2019 (COVID-19) remains unknown.
📊
Key Findings & Data:This study aimed to evaluate the prognostic value of the initial LAR in predicting 30-day mortality in critically ill patients with COVID-19 and compare the initial level of serum lactate and albumin for mortality prediction.
💡
Conclusion & Impact:Patients who died within 30 days had higher lactate (p
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The prognostic role of the initial lactate/albumin ratio (LAR) in critically ill patients with coronavirus disease-2019 (COVID-19) remains unknown. This study aimed to evaluate the prognostic value of the initial LAR in predicting 30-day mortality in critically ill patients with COVID-19 and compare the initial level of serum lactate and albumin for mortality prediction. Materials and Methods: A single-center and observational clinical study between April 2020 and December 2020 were retrospectively performed. Clinical and laboratory variables of patients evaluated in this study were collected within the first 24 hours following the intensive care unit (ICU) admission. Results: A total of 282 critically ill patients with COVID-19 were included in the study. The mean age of the patients was 66.34±12.08 years, wherein 179 (63.5%) were male. Patients who died within 30 days had higher lactate (p

Özet

Amaç: Laktat/albümin oranının (LAR) kritik koronavirüs hastalığı-2019 (COVID-19) olgularındaki prognostik rolü bilinmemektedir. Bu çalışmada, kritik COVID-19 olgularında 30 günlük mortaliteyi tahmin etmede ilk LAR’ın prognostik değerini araştırılması ve mortalite tahmininde serum laktat ve albümin düzeyi ile karşılaştırılması amaçlanmıştır. Gereç ve Yöntem: Tek merkezli retrospektif gözlemsel klinik çalışmaya Nisan 2020 ve Aralık 2020 tarihleri arasında YBÜ’ye kabul edilen olgular dahil edilmiştir. Çalışmada YBÜ’ye kabul edilen kritik COVID-19 hastalarının yatıştan sonraki ilk 24 saat içindeki klinik ve laboratuvar değişkenleri değerlendirilmiştir. Bulgular: Çalışmaya 282 kritik COVID-19 olgusu dahil edilmiştir. Hastaların yaş ortalaması 66,34±12,08 yıl olup, 179’u (%63,5) erkekti. Otuz gün içinde ölen olguların daha yüksek laktat (p

🔖

Cite This Article

DELEN, L. A., KASAPOĞLU, U. S., GÖK, A., ÖZMEN, F., BANAZLI, S. (2022). Lactate/Albumin Ratio as a Prognostic Factor for Short-time Mortality in Critically Ill Patients with Coronavirus Disease-2019. Türk Yoğun Bakım Dergisi, Cilt: 19 - Sayı: 1, 62–72. https://ajindex.com/articles/643417

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62
  2. Skegg D, Gluckman P, Boulton G, Hackmann H, Karim SSA, Piot P, et al. Future scenarios for the COVID-19 pandemic. Lancet 2021;397:777-8
  3. Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy 2021;76:428-55
  4. Ye L, Chen B, Wang Y, Yang Y, Zeng J, Deng G, et al. Prognostic value of liver biochemical parameters for COVID-19 mortality. Ann Hepatol 2021;21:100279
  5. Gharipour A, Razavi R, Gharipour M, Modarres R, Nezafati P, Mirkheshti N. The incidence and outcome of severe hyperlactatemia in critically ill patients. Intern Emerg Med 2021;16:115-23
  6. Haas SA, Lange T, Saugel B, Petzoldt M, Fuhrmann V, Metschke M, et al. Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients. Intensive Care Med 2016;42:202-10
  7. Lee SG, Song J, Park DW, Moon S, Cho HJ, Kim JY, et al. Prognostic value of lactate levels and lactate clearance in sepsis and septic shock with initial hyperlactatemia: A retrospective cohort study according to the Sepsis-3 definitions. Medicine (Baltimore) 2021;100:e24835
  8. Velavan TP, Kieu Linh LT, Kreidenweiss A, Gabor J, Krishna S, Kremsner PG. Longitudinal Monitoring of Lactate in Hospitalized and Ambulatory COVID19 Patients. Am J Trop Med Hyg 2021;104:1041-4
  9. Kendall H, Abreu E, Cheng AL. Serum Albumin Trend Is a Predictor of Mortality in ICU Patients With Sepsis. Biol Res Nurs 2019;21:237-44
  10. Gharipour A, Razavi R, Gharipour M, Mukasa D. Lactate/albumin ratio: An early prognostic marker in critically ill patients. Am J Emerg Med 2020;38:2088-95
  11. Kasapoglu US, Arinc S, Gungor S, Irmak I, Guney P, Aksoy F, et al. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions. Clin Respir J 2016;10:791-9
  12. Akirov A, Masri-Iraqi H, Atamna A, Shimon I. Low Albumin Levels Are Associated with Mortality Risk in Hospitalized Patients. Am J Med 2017;130:1465 e11-e19
  13. Aziz M, Fatima R, Lee-Smith W, Assaly R. The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis. Crit Care 2020;24:255
  14. Alhazzani W, Moller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign: guidelines on the mana